Wit
Tickets and Information
SHOW INFORMATION
Opened Jan 26, 2012
Closes Mar 17, 2012
1hr. 40min.
WHAT IS IT ABOUT?
Margaret Edson's Wit follows brilliant and exacting poetry professor Vivian Bearing (to be played by Cynthia Nixon) as she undergoes experimental treatment for cancer. A scholar who devoted her life to academia, she must now face the irony and injustice of becoming the subject of research.
THEATER/VENUE INFORMATION:
WHAT ARE CRITICS SAYING?
What are other members saying?
Good play, but something missing
This is a brilliant play and while Cynthia Nixon was competent in the role, I felt as if something were lacking. After discussing with friends we came up with gravitas for lack of a better word. Vivian Bearing uses her fierce intelligence as a shield and a weapon, and somehow the weapon part seemed lacking. Nixon lacks the precise iciness that is usually associated with the role. It's still a touching play with some brilliant use of language, but this production seems a little flat. I was happy to see that the New Yorker reviewer agreed with me. I think that was a very accurate review. Sometimes I wonder if the reviewer and I saw the same play, but not this time.
Reviewed by mrc0201
on Thursday, Feb 9th, 2012
Wit
Beautiful play. Great ensemble. Bravo, brava!
Reviewed by easterling
on Friday, Jan 27th, 2012
recommend, approve and/or guarantee such events, or any facts, views, advice and/or information contained therein.
©1999-2012 TheaterMania.com, Inc. All Rights Reserved. Terms of Use & Privacy Policy
Directions & Map
Margaret Edson's moving and insightful play, Wit, currently receiving its Broadway premiere from Manhattan Theatre Club at the Samuel J. Friedman Theatre, deservedly won the Pulitzer Prize in 1999 for its debut Off-Broadway. But while this revival, directed by Lynne Meadow, ably demonstrates the play's power, star Cynthia Nixon proves less than completely convincing in the lead role.
The work centers on Dr. Vivian Bearing (Nixon), a literature professor who has been diagnosed with stage-four metastatic ovarian cancer. She agrees to undergo an experimental chemotherapy regimen, although the chances for recovery are slim and the treatment is potentially as debilitating as the illness (perha[...]